Jump to content

Metastatic melanoma (Q34678227)

From Wikidata

scientific article

Language	Label	Description	Also known as
default for all languages	No label defined
English	Metastatic melanoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Metastatic melanoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

metastatic melanoma

1 reference

based on heuristic

inferred from title

author name string

Sun W

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Schuchter LM

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

Current Treatment Options in Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

193-202

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication type of scholarly work

1 reference

Europe PubMed Central

Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective combination chemo/hormonal therapy for malignant melanoma: experience with three consecutive trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastasectomy in malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Melanoma: chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential chemoimmunotherapy in the treatment of metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Gr

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of taxol in metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons in melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of metastatic melanoma with chemotherapy and biologics

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of taxol in patients with malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in 1,521 melanoma patients with distant metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12057119

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11864-001-0033-5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34678227&oldid=2485281790"